Immune Response Evolution in Peanut Epicutaneous Immunotherapy for Peanut-Allergic Children.

Marie Bastin,Warner W Carr,Carla M Davis,David M Fleischer,Jay A Lieberman,S Shahzad Mustafa,Thibault Helleputte,Timothée Bois,Dianne E Campbell,Todd D Green,Matthew Greenhawt

Allergy（2023）

引用 1|浏览24

暂无评分

摘要

Peanut sIgG4 rise most clearly differentiated Viaskin Peanut versus placebo subjects. sIgG4/sIgE ratios >20.1 and the combination of Ara h 1 and peanut sIgG4/sIgE had moderate ability to predict treatment response and could potentially be useful for clinical monitoring. Additional data are needed to confirm these relationships.

查看译文

关键词

IgE,IgG4,Viaskin Peanut,epicutaneous immunotherapy,peanut allergy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要